The extraordinary growth of multimodal data offers life sciences companies unprecedented opportunities to redefine drug discovery using AI-ready assets. However, fragmented data infrastructures and siloed legacy systems hinder the transition from discovery to impact.
Our playbook explores how organizations can accelerate research with Verily Pre, an AI-native platform for precision health that helps organizations move faster from data to impact.